Concepedia

Isabella C. Glitza Oliva

IC

20

Publications

859

Citations

17

H-Index

2018

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Baylor College of Medicine

Central South University

Second Xiangya Hospital of Central South University

Isabella C. Glitza Oliva is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, radiation oncology, and oncology.

ORCID

Top concepts

Publications per year

2018–2025

20

Publications

20

Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study

Fangwen Zou, David M. Faleck, Anusha Shirwaikar Thomas et al. · Journal for ImmunoTherapy of Cancer · 2021 · 111 citations · Full text

Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy

Sang T. Kim, Yanshuo Chu, Mercy Misoi et al. · Nature Communications · 2022 · 103 citations · Full text

Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease

Leomar Y. Ballester, Isabella C. Glitza Oliva, Dzifa Y. Douse et al. · Journal of Neuropathology & Experimental Neurology · 2018 · 77 citations · Full text

, , +21

Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis

Fangwen Zou, Xuemei Wang, Isabella C. Glitza Oliva et al. · Journal for ImmunoTherapy of Cancer · 2021 · 67 citations · Full text

Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results

Isabella C. Glitza Oliva, Sherise D. Ferguson, Roland L. Bassett et al. · Nature Medicine · 2023 · 67 citations · Full text

Rows per page

1–5 of 20